CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 29 analysts
CRISPR Therapeutics AG has a share price target of US$ 84, revenue growth forecast of 63.6%, and profit growth estimate of -14.3% for FY25, based on top 29 analyst calls.